Skip Navigation Links
 



                     


 



   
    Learn More     Subscribe    
Join Now!      Login
 
 
 
FREE HEALTH
NEWSLETTER
 
 
Walking Quiz
Which of the following in NOT a direct benefit of a regular walking regimen?
 
 
 
 
W
hat Doctors Don't Tell You
 

Special Report: Aspirin resistance - When the risks outweigh the benefits

© What Doctors Don't Tell You (Volume 16, Issue 6)

But it is most likely to mean that high-risk patients - who are also probably those who have been taking a long-term course of aspirin and have developed a tolerance to it - simply aren’t responding to it anymore, no matter how much they take.

And what about those healthy people who are taking aspirin for vague preventative purposes? A recent study of healthy volunteers found that their platelets did not respond well to low-dose aspirin; to be effective, a dose of at least 500 mg/day is required (Circulation, 1997; 95: 63-8).

But, as we already know, high doses of aspirin are linked to a higher incidence of side-effects such as gastrointestinal and cerebrovascular bleeding (Circulation, 2002; 105: 1650-5; Hellenic J Cardiol, 2004; 45: 1-5). Clearly, the potential benefits of aspirin need to be weighed against these risks and the risks of the known side-effects of any alternative drugs.

The clopidogrel connection One such alternative, clopidogrel (Plavix), is a more expensive antiplatelet agent widely prescribed for atherothrombotic disease. It is often used with aspirin to maximise antiplatelet benefit. The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) trial showed that heart patients treated with both aspirin and clopidogrel within 24 hours had a 20 per cent relative-risk reduction in vascular events compared with aspirin alone (N Engl J Med, 2001; 345: 494-502). However, there was also an increased risk of major bleeding with clopidogrel.

But, in a randomised blinded trial of clopidogrel vs aspirin in patients at risk of ischaemia (CAPRIE), clopidogrel proved more effective in reducing cardiovascular risk than aspirin (Lancet, 1996; 348: 1329-39). So, for patients who respond poorly to aspirin, clopidogrel may yet be a better option as it works in a slightly different way.

Nevertheless, as with aspirin, clopidogrel resistance has been reported (Thromb Haemost, 2003; 89: 783-7; Am J Cardiol, 2003; 91: 1123-5). Looking at both drugs together, resistance is seen in more than half the patients chronically taking either aspirin or clopidogrel (Curr Cardiol Rep, 2005; 7: 242-8).

Physicians are now in a bind. Faced with a high-risk and potentially aspirin-resistant patient, they can either prescribe the more expensive treatment in addition to aspirin (increasing the risk of serious side-effects), or they can remove aspirin from the cocktail and rely on clopidogrel - and risk resistance to it instead, and still have the possibility of bleeding.

And should both drugs be offered to all patients, or should clopidogrel or the other, new antiplatelet agents be used only in cases of apparent aspirin-resistance? Given that most cardiovascular patients are already on potentially interacting medications such as ACE inhibitors and statins, it seems imprudent to prescribe anything remotely unnecessary.

To test or not to test? Lab tests such as the platelet-function analyser PFA-100® use blood samples to measure platelet reaction on exposure to aspirin, and may be useful for identifying aspirin resistance in some patients (Thromb Haemost, 2000; 83: 316-21). AspirinWorks is a test that measures levels of thromboxane in the urine - low levels mean the aspirin is working.

But medical opinion is divided as to whether aspirin testing should be routine for high-risk patients. Those against the idea believe that more facts on the mechanism of aspirin resistance are needed. They also question the validity of test results.

Add your comment   CONTINUED      Previous   1  2  3  4  Next   
About The Author
What Doctors Don’t Tell You is one of the few publications in the world that can justifiably claim to solve people's health problems - and even save lives. Our monthly newsletter gives you the facts you won't read anywhere else about what works, what doesn't work and what may harm you in both orthodox and alternative medicine. We'll also tell you how you can prevent illness.......more
Related Articles
 
Share   Facebook   Buzz   Delicious   Digg   Twitter  
 
 
 
 
 
 
From Our Sponsor
 
 
 
 
 
 
Featured Events
Wellness Inventory Certification Training - Level I
     February 18-May 20, 2014
     Los Angeles, CA USA
 
Additional Calendar Links
 
Wellness, Intimacy, dimension!

Search   
Home       Wellness       Health A-Z       Alternative Therapies       Find a Practitioner       Healthy Products       Bookstore       Wellness Inventory
Healthy Kitchen       Healthy Woman       Healthy Man       Healthy Child       Healthy Aging       Wellness Center       Nutrition Center       Fitness Center
Free Newsletter      What Doctor's Don't Tell You      Stevia.com      Discount Lab Tests      First Aid      Global Health Calendar      Privacy Policy     Contact Us

Disclaimer: The information provided on HealthWorld Online is for educational purposes only and IS NOT intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek professional medical advice from your physician or other qualified healthcare provider with any questions you may have regarding a medical condition.